Join
Live feed
·
PRReleasevia Quantisnow
Celularity Inc. logo

Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

ByQuantisnow·Wall Street's wire, on your screen.
CELU· Celularity Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELU (Celularity Inc.) and more on Quantisnow.